— Know what they know.
Not Investment Advice

323990.KQ KOE

Vaxcell-Bio Therapeutics Co., Ltd.
1W: +1.8% 1M: -15.5% 3M: -12.2% YTD: -58.0% 1Y: -54.3% 3Y: -86.2% 5Y: -94.3%
₩4,285.00 ($3.19)
-25.00 (-0.58%)
 
Weekly Expected Move ±7.6%
₩3630 ₩3958 ₩4285 ₩4612 ₩4940
KOE · Healthcare · Biotechnology · Tech Score Neutral · Power 43 · ₩99.3B mcap · 19M float · 0.901% daily turnover

📊 Key Metrics

TTM
₩7B
Revenue
+17.3% YoY
₩-14,918M
Net Income
-22.6% YoY
₩-17,936M
Free Cash Flow
-40.1% YoY
-40.1%
Gross Margin
-308.5%
Op. Margin
-249.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-24.6%
ROA-22.7%
ROIC-33.2%

Valuation

P/E-6.7
P/B1.9
EV/EBITDA-7.8

Leverage

Debt/Equity0.03
Current Ratio5.56
Interest Cov.-80.4x

Quality Scores

Piotroski F3/9
Altman Z10.88
Beneish M-3.53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms